NEW YORK, Feb. 1 - Celera Genomics has licensed Discovery System to the United Kingdom Medical Research Council, the company said on Thursday.
The multi-year deal makes Celera's database available to a consortium of UK academic researchers.
Registering provides access to this and other free content.
Already have an account?Login Now.
An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.
Research funding in Canada is to remain mostly the same, ScienceInsider reports.
In Science this week: random DNA replication errors play role in cancer, and more.
The Bill and Melinda Gates Foundation embarks on an open-access publishing path.